About Us
At Crucial Innovations Corp (CINV), we are setting a new precedent for producing top-tier cannabis cultivars and elevating quality across the global supply chain.
We relentlessly champion plant medicine’s full therapy potential through an end-to-end solution that helps to rebuild a fundamentally broken system. CINV is not just offering medicine; we’re crafting a new paradigm of trust and efficacy in the medicinal cannabis industry.
Our Vertically Integrated Approach
Our meticulous oversight ensures top-notch quality and consistency from seed to sale and beyond. At our 17,000sqm farm in South Africa, we handle R&D, cultivation, and processing. To increase yield, we partner with additional outgrow partners who are licensed to cultivate our genetics. We use a blend of greenhouse and indoor grows to yield around 2200kg-3000kg annually. We oversee testing, distribution, and sales through our reliable European partners and CQC-registered clinics.
Unparalleled Medical Cannabis
Leveraging award-winning techniques, our team creates exclusive strains with exceptional therapeutic properties. We go beyond isolated compounds to retain the full spectrum of synergistic cannabinoids, terpenes, and flavonoids essential for personalised care.
We harness cultivation science, consumer data and continuous innovation to address diverse patient needs. Our knowledge of the US legacy market has allowed our team to create the perfect hybrid – top-tier, potent cannabis cultivars, tailored for medical patients.
Medicinal Cannabis & Psilocybin Innovation
As research reveals psilocybin’s promise for treating mental health conditions, we are applying to pioneer its compassionate, regulated use through our R&D licence. We aim to develop safe, effective psilocybin therapies that can transform patient wellbeing and tackle the growing global mental health crisis.
Our Mission
To expertly navigate the power of organic medicine, offering a seamless journey from seed to healing.
Our commitment is to provide access to high-quality, safe treatments, ensuring they reach patients through licensed clinics and an online pharmaceutical dispensary. By harmonising nature’s healing power with stringent regulatory standards, CINV is not just offering medicine; we’re crafting a new paradigm of trust and efficacy in the medicinal cannabis industry.
Our Vision
To build a future where we are all empowered to drive our own healthcare journey
We dream of a world where healthcare is fundamentally reoriented. We want patients to be connected to the healing power of nature through our seamless and integrated network of cultivation, distribution, and care.
The future we envisage is not just a service, but a synergistic ecosystem that evolves and adapts. In this new era, CINV is the architect of a healthcare landscape that thrives on collaboration, transparency, and a relentless commitment to delivering quality.
Meet our team
Contact us today to learn more about our life-changing medicinal cannabis products and patient-centered services.
JP Doran
CEO, CINV
Timothy Ambrose
Chairman, CINV
Darlington Mazvidza
CFO, CINV
Bernard Pieters
COO, Ember Pharms
Chris Ioannou
Head of Cultivation, CINV
Kyle Snoxell
Business Development Manager, Ember Pharms
Our cultivation techniques produce premium cannabis flower with remarkable structure, yields, THC levels, and terpene profiles.
Through our exceptional genetics and strategic alliances, we are poised to supply the pharmaceutical industry with unparalleled GMP- Flower and GMP-Oil.
